Clinical Trials · NCT07102056
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Enrollment
- 152
- Start date
- Jan 2026
- Locations
- See registry
- Primary endpoint
- Diagnostic efficacy